CD46 and Oncologic Interactions: Friendly Fire against Cancer
One of the most challenging aspects of cancer therapeutics is target selection. Recently, CD46 (membrane cofactor protein; MCP) has emerged as a key player in both malignant transformation as well as in cancer treatments. Normally a regulator of complement activation, CD46 is co-expressed as four pr...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2020-11-01
|
| Col·lecció: | Antibodies |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2073-4468/9/4/59 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|